Insights into novel emerging epigenetic drugs in myeloid malignancies

DOI: 10.1177/2040620719866081

Keywords: acute myeloid leukemia, BET inhibitors, demethylases, DOT1L inhibitors, epigenetic modifications, histone modification, hypomethylating agents, IDH inhibitors, LSD1 inhibitors, myelodysplastic syndrome, novel agents

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text